nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—CYP3A5—Propranolol—migraine	0.102	0.203	CbGbCtD
Vardenafil—CYP3A5—Amitriptyline—migraine	0.0881	0.176	CbGbCtD
Vardenafil—CYP3A5—Valproic Acid—migraine	0.0803	0.16	CbGbCtD
Vardenafil—CYP3A5—Verapamil—migraine	0.0699	0.14	CbGbCtD
Vardenafil—CYP3A4—Propranolol—migraine	0.0397	0.0793	CbGbCtD
Vardenafil—CYP3A4—Amitriptyline—migraine	0.0343	0.0686	CbGbCtD
Vardenafil—CYP3A4—Valproic Acid—migraine	0.0313	0.0625	CbGbCtD
Vardenafil—CYP3A4—Topiramate—migraine	0.0282	0.0564	CbGbCtD
Vardenafil—CYP3A4—Verapamil—migraine	0.0273	0.0544	CbGbCtD
Vardenafil—PDE6H—pineal body—migraine	0.0217	0.281	CbGeAlD
Vardenafil—PDE5A—blood vessel—migraine	0.00472	0.0611	CbGeAlD
Vardenafil—PDE6H—head—migraine	0.00374	0.0485	CbGeAlD
Vardenafil—PDE11A—G alpha (s) signalling events—RAMP1—migraine	0.00371	0.0551	CbGpPWpGaD
Vardenafil—PDE11A—G alpha (s) signalling events—CALCRL—migraine	0.00371	0.0551	CbGpPWpGaD
Vardenafil—PDE6G—head—migraine	0.0036	0.0467	CbGeAlD
Vardenafil—PDE6H—nervous system—migraine	0.00355	0.046	CbGeAlD
Vardenafil—PDE6H—central nervous system—migraine	0.00342	0.0443	CbGeAlD
Vardenafil—PDE10A—G alpha (s) signalling events—CALCRL—migraine	0.00331	0.0491	CbGpPWpGaD
Vardenafil—PDE10A—G alpha (s) signalling events—RAMP1—migraine	0.00331	0.0491	CbGpPWpGaD
Vardenafil—PDE6H—brain—migraine	0.00271	0.0351	CbGeAlD
Vardenafil—PDE11A—brain—migraine	0.00271	0.0351	CbGeAlD
Vardenafil—PDE6G—Diseases associated with visual transduction—LRP1—migraine	0.0025	0.0371	CbGpPWpGaD
Vardenafil—PDE10A—head—migraine	0.00243	0.0315	CbGeAlD
Vardenafil—PDE1B—head—migraine	0.00241	0.0313	CbGeAlD
Vardenafil—PDE10A—nervous system—migraine	0.00231	0.0299	CbGeAlD
Vardenafil—PDE1B—nervous system—migraine	0.00229	0.0296	CbGeAlD
Vardenafil—PDE10A—central nervous system—migraine	0.00222	0.0288	CbGeAlD
Vardenafil—PDE1B—central nervous system—migraine	0.0022	0.0285	CbGeAlD
Vardenafil—PDE10A—cerebellum—migraine	0.00217	0.0281	CbGeAlD
Vardenafil—PDE1B—cerebellum—migraine	0.00215	0.0279	CbGeAlD
Vardenafil—PDE5A—cardiovascular system—migraine	0.0021	0.0272	CbGeAlD
Vardenafil—PDE10A—brain—migraine	0.00176	0.0229	CbGeAlD
Vardenafil—PDE1B—brain—migraine	0.00175	0.0226	CbGeAlD
Vardenafil—PDE1B—G alpha (s) signalling events—CALCRL—migraine	0.00168	0.0249	CbGpPWpGaD
Vardenafil—PDE1B—G alpha (s) signalling events—RAMP1—migraine	0.00168	0.0249	CbGpPWpGaD
Vardenafil—PDE11A—G alpha (s) signalling events—NPS—migraine	0.00155	0.023	CbGpPWpGaD
Vardenafil—PDE5A—head—migraine	0.00142	0.0185	CbGeAlD
Vardenafil—PDE11A—G alpha (s) signalling events—CALCA—migraine	0.00142	0.0211	CbGpPWpGaD
Vardenafil—PDE10A—G alpha (s) signalling events—NPS—migraine	0.00138	0.0205	CbGpPWpGaD
Vardenafil—PDE5A—nervous system—migraine	0.00135	0.0175	CbGeAlD
Vardenafil—PDE11A—G alpha (s) signalling events—HTR7—migraine	0.00133	0.0198	CbGpPWpGaD
Vardenafil—PDE5A—central nervous system—migraine	0.0013	0.0168	CbGeAlD
Vardenafil—PDE5A—cerebellum—migraine	0.00127	0.0165	CbGeAlD
Vardenafil—PDE10A—G alpha (s) signalling events—CALCA—migraine	0.00127	0.0188	CbGpPWpGaD
Vardenafil—PDE10A—G alpha (s) signalling events—HTR7—migraine	0.00119	0.0176	CbGpPWpGaD
Vardenafil—PDE5A—brain—migraine	0.00103	0.0134	CbGeAlD
Vardenafil—PDE11A—GPCR downstream signaling—CALCRL—migraine	0.000762	0.0113	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—RAMP1—migraine	0.000762	0.0113	CbGpPWpGaD
Vardenafil—PDE1B—G alpha (s) signalling events—NPS—migraine	0.0007	0.0104	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—CALCRL—migraine	0.000692	0.0103	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—RAMP1—migraine	0.000692	0.0103	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—CALCRL—migraine	0.000679	0.0101	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—RAMP1—migraine	0.000679	0.0101	CbGpPWpGaD
Vardenafil—PDE1B—G alpha (s) signalling events—CALCA—migraine	0.000642	0.00954	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—RAMP1—migraine	0.000616	0.00915	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—CALCRL—migraine	0.000616	0.00915	CbGpPWpGaD
Vardenafil—PDE1B—G alpha (s) signalling events—HTR7—migraine	0.000601	0.00892	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—HTR1D—migraine	0.000553	0.00822	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—HTR2B—migraine	0.000514	0.00764	CbGpPWpGaD
Vardenafil—Pain—Verapamil—migraine	0.000511	0.00144	CcSEcCtD
Vardenafil—Vomiting—Amitriptyline—migraine	0.000508	0.00143	CcSEcCtD
Vardenafil—Angina pectoris—Topiramate—migraine	0.000506	0.00143	CcSEcCtD
Vardenafil—Rash—Amitriptyline—migraine	0.000503	0.00142	CcSEcCtD
Vardenafil—Dermatitis—Amitriptyline—migraine	0.000503	0.00142	CcSEcCtD
Vardenafil—Back pain—Valproic Acid—migraine	0.000502	0.00142	CcSEcCtD
Vardenafil—PDE11A—Signaling by GPCR—HTR1D—migraine	0.000502	0.00746	CbGpPWpGaD
Vardenafil—Headache—Amitriptyline—migraine	0.0005	0.00141	CcSEcCtD
Vardenafil—Muscle spasms—Valproic Acid—migraine	0.000499	0.00141	CcSEcCtD
Vardenafil—Eye disorder—Timolol—migraine	0.000496	0.0014	CcSEcCtD
Vardenafil—Rhinitis—Gabapentin—migraine	0.000496	0.0014	CcSEcCtD
Vardenafil—Tinnitus—Timolol—migraine	0.000495	0.0014	CcSEcCtD
Vardenafil—Haemorrhage—Gabapentin—migraine	0.000495	0.0014	CcSEcCtD
Vardenafil—PDE10A—GPCR downstream signaling—HTR1D—migraine	0.000493	0.00732	CbGpPWpGaD
Vardenafil—Cardiac disorder—Timolol—migraine	0.000493	0.00139	CcSEcCtD
Vardenafil—Feeling abnormal—Verapamil—migraine	0.000493	0.00139	CcSEcCtD
Vardenafil—Hypoaesthesia—Gabapentin—migraine	0.000492	0.00139	CcSEcCtD
Vardenafil—Pharyngitis—Gabapentin—migraine	0.000491	0.00138	CcSEcCtD
Vardenafil—Vision blurred—Valproic Acid—migraine	0.00049	0.00138	CcSEcCtD
Vardenafil—Urinary tract disorder—Gabapentin—migraine	0.000489	0.00138	CcSEcCtD
Vardenafil—Connective tissue disorder—Gabapentin—migraine	0.000486	0.00137	CcSEcCtD
Vardenafil—Urethral disorder—Gabapentin—migraine	0.000485	0.00137	CcSEcCtD
Vardenafil—Ill-defined disorder—Valproic Acid—migraine	0.000482	0.00136	CcSEcCtD
Vardenafil—Angiopathy—Timolol—migraine	0.000482	0.00136	CcSEcCtD
Vardenafil—Immune system disorder—Timolol—migraine	0.00048	0.00135	CcSEcCtD
Vardenafil—Hypersensitivity—Propranolol—migraine	0.000479	0.00135	CcSEcCtD
Vardenafil—Mediastinal disorder—Timolol—migraine	0.000479	0.00135	CcSEcCtD
Vardenafil—Visual impairment—Gabapentin—migraine	0.000477	0.00134	CcSEcCtD
Vardenafil—Angioedema—Valproic Acid—migraine	0.000475	0.00134	CcSEcCtD
Vardenafil—Photosensitivity reaction—Topiramate—migraine	0.000475	0.00134	CcSEcCtD
Vardenafil—Nausea—Amitriptyline—migraine	0.000474	0.00134	CcSEcCtD
Vardenafil—Malaise—Valproic Acid—migraine	0.000468	0.00132	CcSEcCtD
Vardenafil—PDE11A—Signaling by GPCR—HTR2B—migraine	0.000467	0.00694	CbGpPWpGaD
Vardenafil—Vertigo—Valproic Acid—migraine	0.000467	0.00132	CcSEcCtD
Vardenafil—Asthenia—Propranolol—migraine	0.000466	0.00132	CcSEcCtD
Vardenafil—Mental disorder—Timolol—migraine	0.000465	0.00131	CcSEcCtD
Vardenafil—Infestation—Topiramate—migraine	0.000464	0.00131	CcSEcCtD
Vardenafil—Infestation NOS—Topiramate—migraine	0.000464	0.00131	CcSEcCtD
Vardenafil—Erythema—Timolol—migraine	0.000462	0.0013	CcSEcCtD
Vardenafil—Eye disorder—Gabapentin—migraine	0.000462	0.0013	CcSEcCtD
Vardenafil—Tinnitus—Gabapentin—migraine	0.000461	0.0013	CcSEcCtD
Vardenafil—Cardiac disorder—Gabapentin—migraine	0.000459	0.00129	CcSEcCtD
Vardenafil—Palpitations—Valproic Acid—migraine	0.000459	0.00129	CcSEcCtD
Vardenafil—PDE10A—GPCR downstream signaling—HTR2B—migraine	0.000458	0.00681	CbGpPWpGaD
Vardenafil—Conjunctivitis—Topiramate—migraine	0.000451	0.00127	CcSEcCtD
Vardenafil—PDE10A—Signaling by GPCR—HTR1D—migraine	0.000448	0.00665	CbGpPWpGaD
Vardenafil—Immune system disorder—Gabapentin—migraine	0.000447	0.00126	CcSEcCtD
Vardenafil—Mediastinal disorder—Gabapentin—migraine	0.000446	0.00126	CcSEcCtD
Vardenafil—Diarrhoea—Propranolol—migraine	0.000445	0.00125	CcSEcCtD
Vardenafil—Myalgia—Valproic Acid—migraine	0.000442	0.00125	CcSEcCtD
Vardenafil—Chest pain—Valproic Acid—migraine	0.000442	0.00125	CcSEcCtD
Vardenafil—Arthralgia—Valproic Acid—migraine	0.000442	0.00125	CcSEcCtD
Vardenafil—Haematuria—Topiramate—migraine	0.000442	0.00125	CcSEcCtD
Vardenafil—Anxiety—Valproic Acid—migraine	0.000441	0.00124	CcSEcCtD
Vardenafil—Hypersensitivity—Verapamil—migraine	0.000441	0.00124	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000439	0.00124	CcSEcCtD
Vardenafil—Epistaxis—Topiramate—migraine	0.000437	0.00123	CcSEcCtD
Vardenafil—Discomfort—Valproic Acid—migraine	0.000437	0.00123	CcSEcCtD
Vardenafil—Vision blurred—Timolol—migraine	0.000436	0.00123	CcSEcCtD
Vardenafil—Sinusitis—Topiramate—migraine	0.000435	0.00123	CcSEcCtD
Vardenafil—Mental disorder—Gabapentin—migraine	0.000433	0.00122	CcSEcCtD
Vardenafil—Dry mouth—Valproic Acid—migraine	0.000433	0.00122	CcSEcCtD
Vardenafil—Erythema—Gabapentin—migraine	0.000431	0.00121	CcSEcCtD
Vardenafil—Dizziness—Propranolol—migraine	0.00043	0.00121	CcSEcCtD
Vardenafil—Asthenia—Verapamil—migraine	0.000429	0.00121	CcSEcCtD
Vardenafil—Anaphylactic shock—Valproic Acid—migraine	0.000424	0.0012	CcSEcCtD
Vardenafil—Pruritus—Verapamil—migraine	0.000423	0.00119	CcSEcCtD
Vardenafil—Angioedema—Timolol—migraine	0.000423	0.00119	CcSEcCtD
Vardenafil—Infection—Valproic Acid—migraine	0.000421	0.00119	CcSEcCtD
Vardenafil—CYP3A4—nervous system—migraine	0.000421	0.00545	CbGeAlD
Vardenafil—Haemoglobin—Topiramate—migraine	0.000418	0.00118	CcSEcCtD
Vardenafil—Rhinitis—Topiramate—migraine	0.000417	0.00118	CcSEcCtD
Vardenafil—Back pain—Gabapentin—migraine	0.000417	0.00117	CcSEcCtD
Vardenafil—PDE10A—Signaling by GPCR—HTR2B—migraine	0.000416	0.00618	CbGpPWpGaD
Vardenafil—Haemorrhage—Topiramate—migraine	0.000416	0.00117	CcSEcCtD
Vardenafil—Nervous system disorder—Valproic Acid—migraine	0.000416	0.00117	CcSEcCtD
Vardenafil—Vertigo—Timolol—migraine	0.000415	0.00117	CcSEcCtD
Vardenafil—Syncope—Timolol—migraine	0.000415	0.00117	CcSEcCtD
Vardenafil—Hypoaesthesia—Topiramate—migraine	0.000414	0.00117	CcSEcCtD
Vardenafil—Muscle spasms—Gabapentin—migraine	0.000414	0.00117	CcSEcCtD
Vardenafil—Tachycardia—Valproic Acid—migraine	0.000414	0.00117	CcSEcCtD
Vardenafil—Vomiting—Propranolol—migraine	0.000413	0.00117	CcSEcCtD
Vardenafil—Pharyngitis—Topiramate—migraine	0.000413	0.00116	CcSEcCtD
Vardenafil—Skin disorder—Valproic Acid—migraine	0.000412	0.00116	CcSEcCtD
Vardenafil—Urinary tract disorder—Topiramate—migraine	0.000411	0.00116	CcSEcCtD
Vardenafil—Hyperhidrosis—Valproic Acid—migraine	0.00041	0.00116	CcSEcCtD
Vardenafil—Rash—Propranolol—migraine	0.00041	0.00116	CcSEcCtD
Vardenafil—Dermatitis—Propranolol—migraine	0.000409	0.00115	CcSEcCtD
Vardenafil—Diarrhoea—Verapamil—migraine	0.000409	0.00115	CcSEcCtD
Vardenafil—Connective tissue disorder—Topiramate—migraine	0.000409	0.00115	CcSEcCtD
Vardenafil—Palpitations—Timolol—migraine	0.000409	0.00115	CcSEcCtD
Vardenafil—PDE11A—Signaling Pathways—CALCRL—migraine	0.000409	0.00607	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—RAMP1—migraine	0.000409	0.00607	CbGpPWpGaD
Vardenafil—Urethral disorder—Topiramate—migraine	0.000408	0.00115	CcSEcCtD
Vardenafil—Loss of consciousness—Timolol—migraine	0.000406	0.00115	CcSEcCtD
Vardenafil—Vision blurred—Gabapentin—migraine	0.000406	0.00114	CcSEcCtD
Vardenafil—CYP3A4—central nervous system—migraine	0.000405	0.00525	CbGeAlD
Vardenafil—Visual impairment—Topiramate—migraine	0.000401	0.00113	CcSEcCtD
Vardenafil—Ill-defined disorder—Gabapentin—migraine	0.0004	0.00113	CcSEcCtD
Vardenafil—Hypotension—Valproic Acid—migraine	0.000396	0.00112	CcSEcCtD
Vardenafil—Dizziness—Verapamil—migraine	0.000395	0.00112	CcSEcCtD
Vardenafil—Myalgia—Timolol—migraine	0.000394	0.00111	CcSEcCtD
Vardenafil—Chest pain—Timolol—migraine	0.000394	0.00111	CcSEcCtD
Vardenafil—Arthralgia—Timolol—migraine	0.000394	0.00111	CcSEcCtD
Vardenafil—Angioedema—Gabapentin—migraine	0.000393	0.00111	CcSEcCtD
Vardenafil—Anxiety—Timolol—migraine	0.000392	0.00111	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000391	0.0011	CcSEcCtD
Vardenafil—Discomfort—Timolol—migraine	0.000389	0.0011	CcSEcCtD
Vardenafil—Eye disorder—Topiramate—migraine	0.000389	0.0011	CcSEcCtD
Vardenafil—Malaise—Gabapentin—migraine	0.000388	0.0011	CcSEcCtD
Vardenafil—Tinnitus—Topiramate—migraine	0.000388	0.00109	CcSEcCtD
Vardenafil—Vertigo—Gabapentin—migraine	0.000387	0.00109	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Valproic Acid—migraine	0.000386	0.00109	CcSEcCtD
Vardenafil—Flushing—Topiramate—migraine	0.000386	0.00109	CcSEcCtD
Vardenafil—Cardiac disorder—Topiramate—migraine	0.000386	0.00109	CcSEcCtD
Vardenafil—Syncope—Gabapentin—migraine	0.000386	0.00109	CcSEcCtD
Vardenafil—Nausea—Propranolol—migraine	0.000386	0.00109	CcSEcCtD
Vardenafil—Dry mouth—Timolol—migraine	0.000385	0.00109	CcSEcCtD
Vardenafil—Insomnia—Valproic Acid—migraine	0.000383	0.00108	CcSEcCtD
Vardenafil—Paraesthesia—Valproic Acid—migraine	0.000381	0.00107	CcSEcCtD
Vardenafil—Palpitations—Gabapentin—migraine	0.000381	0.00107	CcSEcCtD
Vardenafil—Vomiting—Verapamil—migraine	0.00038	0.00107	CcSEcCtD
Vardenafil—Loss of consciousness—Gabapentin—migraine	0.000378	0.00107	CcSEcCtD
Vardenafil—Dyspnoea—Valproic Acid—migraine	0.000378	0.00107	CcSEcCtD
Vardenafil—Angiopathy—Topiramate—migraine	0.000378	0.00106	CcSEcCtD
Vardenafil—Anaphylactic shock—Timolol—migraine	0.000377	0.00106	CcSEcCtD
Vardenafil—Rash—Verapamil—migraine	0.000377	0.00106	CcSEcCtD
Vardenafil—Somnolence—Valproic Acid—migraine	0.000377	0.00106	CcSEcCtD
Vardenafil—Dermatitis—Verapamil—migraine	0.000377	0.00106	CcSEcCtD
Vardenafil—Immune system disorder—Topiramate—migraine	0.000376	0.00106	CcSEcCtD
Vardenafil—Mediastinal disorder—Topiramate—migraine	0.000375	0.00106	CcSEcCtD
Vardenafil—Infection—Timolol—migraine	0.000375	0.00106	CcSEcCtD
Vardenafil—Headache—Verapamil—migraine	0.000375	0.00106	CcSEcCtD
Vardenafil—PDE6G—Signaling Pathways—RAMP1—migraine	0.000374	0.00555	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CALCRL—migraine	0.000374	0.00555	CbGpPWpGaD
Vardenafil—Dyspepsia—Valproic Acid—migraine	0.000373	0.00105	CcSEcCtD
Vardenafil—Convulsion—Gabapentin—migraine	0.000373	0.00105	CcSEcCtD
Vardenafil—Shock—Timolol—migraine	0.000371	0.00105	CcSEcCtD
Vardenafil—Nervous system disorder—Timolol—migraine	0.00037	0.00104	CcSEcCtD
Vardenafil—Arthralgia—Gabapentin—migraine	0.000367	0.00103	CcSEcCtD
Vardenafil—Chest pain—Gabapentin—migraine	0.000367	0.00103	CcSEcCtD
Vardenafil—Myalgia—Gabapentin—migraine	0.000367	0.00103	CcSEcCtD
Vardenafil—Skin disorder—Timolol—migraine	0.000367	0.00103	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Valproic Acid—migraine	0.000366	0.00103	CcSEcCtD
Vardenafil—Anxiety—Gabapentin—migraine	0.000365	0.00103	CcSEcCtD
Vardenafil—Hyperhidrosis—Timolol—migraine	0.000365	0.00103	CcSEcCtD
Vardenafil—Mental disorder—Topiramate—migraine	0.000365	0.00103	CcSEcCtD
Vardenafil—PDE10A—Signaling Pathways—CALCRL—migraine	0.000364	0.00541	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—RAMP1—migraine	0.000364	0.00541	CbGpPWpGaD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000364	0.00103	CcSEcCtD
Vardenafil—Pain—Valproic Acid—migraine	0.000363	0.00102	CcSEcCtD
Vardenafil—Erythema—Topiramate—migraine	0.000362	0.00102	CcSEcCtD
Vardenafil—Discomfort—Gabapentin—migraine	0.000362	0.00102	CcSEcCtD
Vardenafil—Dry mouth—Gabapentin—migraine	0.000359	0.00101	CcSEcCtD
Vardenafil—Nausea—Verapamil—migraine	0.000355	0.001	CcSEcCtD
Vardenafil—Hypotension—Timolol—migraine	0.000353	0.000995	CcSEcCtD
Vardenafil—Anaphylactic shock—Gabapentin—migraine	0.000351	0.000991	CcSEcCtD
Vardenafil—Back pain—Topiramate—migraine	0.00035	0.000988	CcSEcCtD
Vardenafil—Feeling abnormal—Valproic Acid—migraine	0.000349	0.000985	CcSEcCtD
Vardenafil—Infection—Gabapentin—migraine	0.000349	0.000985	CcSEcCtD
Vardenafil—Muscle spasms—Topiramate—migraine	0.000348	0.000982	CcSEcCtD
Vardenafil—Gastrointestinal pain—Valproic Acid—migraine	0.000347	0.000978	CcSEcCtD
Vardenafil—Shock—Gabapentin—migraine	0.000346	0.000975	CcSEcCtD
Vardenafil—Nervous system disorder—Gabapentin—migraine	0.000345	0.000972	CcSEcCtD
Vardenafil—PDE1B—GPCR downstream signaling—RAMP1—migraine	0.000344	0.00511	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CALCRL—migraine	0.000344	0.00511	CbGpPWpGaD
Vardenafil—Musculoskeletal discomfort—Timolol—migraine	0.000344	0.00097	CcSEcCtD
Vardenafil—Tachycardia—Gabapentin—migraine	0.000343	0.000967	CcSEcCtD
Vardenafil—Vision blurred—Topiramate—migraine	0.000341	0.000963	CcSEcCtD
Vardenafil—Skin disorder—Gabapentin—migraine	0.000341	0.000963	CcSEcCtD
Vardenafil—Insomnia—Timolol—migraine	0.000341	0.000963	CcSEcCtD
Vardenafil—Hyperhidrosis—Gabapentin—migraine	0.00034	0.000958	CcSEcCtD
Vardenafil—Paraesthesia—Timolol—migraine	0.000339	0.000956	CcSEcCtD
Vardenafil—Dyspnoea—Timolol—migraine	0.000336	0.000949	CcSEcCtD
Vardenafil—Ill-defined disorder—Topiramate—migraine	0.000336	0.000948	CcSEcCtD
Vardenafil—Somnolence—Timolol—migraine	0.000336	0.000946	CcSEcCtD
Vardenafil—PDE11A—GPCR downstream signaling—HTR1B—migraine	0.000335	0.00498	CbGpPWpGaD
Vardenafil—Abdominal pain—Valproic Acid—migraine	0.000335	0.000945	CcSEcCtD
Vardenafil—Dyspepsia—Timolol—migraine	0.000332	0.000937	CcSEcCtD
Vardenafil—Hypotension—Gabapentin—migraine	0.000328	0.000926	CcSEcCtD
Vardenafil—Malaise—Topiramate—migraine	0.000327	0.000921	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Timolol—migraine	0.000326	0.000919	CcSEcCtD
Vardenafil—Vertigo—Topiramate—migraine	0.000325	0.000918	CcSEcCtD
Vardenafil—Syncope—Topiramate—migraine	0.000325	0.000916	CcSEcCtD
Vardenafil—Pain—Timolol—migraine	0.000323	0.00091	CcSEcCtD
Vardenafil—PDE11A—GPCR downstream signaling—HTR1A—migraine	0.000323	0.00479	CbGpPWpGaD
Vardenafil—Musculoskeletal discomfort—Gabapentin—migraine	0.00032	0.000903	CcSEcCtD
Vardenafil—Palpitations—Topiramate—migraine	0.00032	0.000903	CcSEcCtD
Vardenafil—Loss of consciousness—Topiramate—migraine	0.000318	0.000898	CcSEcCtD
Vardenafil—Insomnia—Gabapentin—migraine	0.000318	0.000896	CcSEcCtD
Vardenafil—PDE11A—GPCR downstream signaling—TAC1—migraine	0.000318	0.00472	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—NPS—migraine	0.000318	0.00472	CbGpPWpGaD
Vardenafil—PDE6G—Disease—LRP1—migraine	0.000317	0.00471	CbGpPWpGaD
Vardenafil—Paraesthesia—Gabapentin—migraine	0.000316	0.00089	CcSEcCtD
Vardenafil—Convulsion—Topiramate—migraine	0.000314	0.000885	CcSEcCtD
Vardenafil—Dyspnoea—Gabapentin—migraine	0.000313	0.000884	CcSEcCtD
Vardenafil—Somnolence—Gabapentin—migraine	0.000312	0.000881	CcSEcCtD
Vardenafil—PDE1B—Signaling by GPCR—RAMP1—migraine	0.000312	0.00464	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CALCRL—migraine	0.000312	0.00464	CbGpPWpGaD
Vardenafil—Hypersensitivity—Valproic Acid—migraine	0.000312	0.000881	CcSEcCtD
Vardenafil—PDE11A—GPCR downstream signaling—HTR2C—migraine	0.000312	0.00463	CbGpPWpGaD
Vardenafil—Feeling abnormal—Timolol—migraine	0.000311	0.000877	CcSEcCtD
Vardenafil—Dyspepsia—Gabapentin—migraine	0.000309	0.000872	CcSEcCtD
Vardenafil—Gastrointestinal pain—Timolol—migraine	0.000309	0.00087	CcSEcCtD
Vardenafil—Arthralgia—Topiramate—migraine	0.000308	0.00087	CcSEcCtD
Vardenafil—Chest pain—Topiramate—migraine	0.000308	0.00087	CcSEcCtD
Vardenafil—Myalgia—Topiramate—migraine	0.000308	0.00087	CcSEcCtD
Vardenafil—Anxiety—Topiramate—migraine	0.000307	0.000867	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000306	0.000864	CcSEcCtD
Vardenafil—Discomfort—Topiramate—migraine	0.000305	0.000859	CcSEcCtD
Vardenafil—PDE11A—Signaling by GPCR—HTR1B—migraine	0.000304	0.00452	CbGpPWpGaD
Vardenafil—Asthenia—Valproic Acid—migraine	0.000304	0.000858	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Gabapentin—migraine	0.000303	0.000856	CcSEcCtD
Vardenafil—PDE11A—GPCR downstream signaling—EDNRA—migraine	0.000303	0.0045	CbGpPWpGaD
Vardenafil—Dry mouth—Topiramate—migraine	0.000302	0.000851	CcSEcCtD
Vardenafil—Pain—Gabapentin—migraine	0.000301	0.000848	CcSEcCtD
Vardenafil—Pruritus—Valproic Acid—migraine	0.0003	0.000846	CcSEcCtD
Vardenafil—PDE10A—GPCR downstream signaling—HTR1B—migraine	0.000299	0.00444	CbGpPWpGaD
Vardenafil—Abdominal pain—Timolol—migraine	0.000298	0.000841	CcSEcCtD
Vardenafil—PDE11A—Signaling Pathways—HTR1D—migraine	0.000297	0.00441	CbGpPWpGaD
Vardenafil—Infection—Topiramate—migraine	0.000294	0.000828	CcSEcCtD
Vardenafil—PDE11A—Signaling by GPCR—HTR1A—migraine	0.000293	0.00435	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—CALCA—migraine	0.000292	0.00433	CbGpPWpGaD
Vardenafil—Shock—Topiramate—migraine	0.000291	0.00082	CcSEcCtD
Vardenafil—Diarrhoea—Valproic Acid—migraine	0.00029	0.000818	CcSEcCtD
Vardenafil—Nervous system disorder—Topiramate—migraine	0.00029	0.000818	CcSEcCtD
Vardenafil—Feeling abnormal—Gabapentin—migraine	0.00029	0.000817	CcSEcCtD
Vardenafil—PDE11A—Signaling by GPCR—NPS—migraine	0.000289	0.00429	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—TAC1—migraine	0.000289	0.00429	CbGpPWpGaD
Vardenafil—Tachycardia—Topiramate—migraine	0.000289	0.000814	CcSEcCtD
Vardenafil—PDE10A—GPCR downstream signaling—HTR1A—migraine	0.000288	0.00427	CbGpPWpGaD
Vardenafil—Gastrointestinal pain—Gabapentin—migraine	0.000287	0.00081	CcSEcCtD
Vardenafil—Skin disorder—Topiramate—migraine	0.000287	0.00081	CcSEcCtD
Vardenafil—Hyperhidrosis—Topiramate—migraine	0.000286	0.000806	CcSEcCtD
Vardenafil—PDE10A—GPCR downstream signaling—TAC1—migraine	0.000283	0.00421	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—NPS—migraine	0.000283	0.00421	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—HTR2C—migraine	0.000283	0.0042	CbGpPWpGaD
Vardenafil—Dizziness—Valproic Acid—migraine	0.00028	0.000791	CcSEcCtD
Vardenafil—Hypersensitivity—Timolol—migraine	0.000278	0.000784	CcSEcCtD
Vardenafil—Abdominal pain—Gabapentin—migraine	0.000278	0.000784	CcSEcCtD
Vardenafil—PDE10A—GPCR downstream signaling—HTR2C—migraine	0.000278	0.00412	CbGpPWpGaD
Vardenafil—Hypotension—Topiramate—migraine	0.000276	0.000779	CcSEcCtD
Vardenafil—PDE11A—Signaling Pathways—HTR2B—migraine	0.000276	0.0041	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—EDNRA—migraine	0.000275	0.00409	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—HTR7—migraine	0.000273	0.00405	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HTR1D—migraine	0.000271	0.00403	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—HTR1B—migraine	0.000271	0.00403	CbGpPWpGaD
Vardenafil—Asthenia—Timolol—migraine	0.000271	0.000764	CcSEcCtD
Vardenafil—PDE10A—GPCR downstream signaling—EDNRA—migraine	0.00027	0.00401	CbGpPWpGaD
Vardenafil—Vomiting—Valproic Acid—migraine	0.00027	0.00076	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Topiramate—migraine	0.000269	0.00076	CcSEcCtD
Vardenafil—Insomnia—Topiramate—migraine	0.000267	0.000754	CcSEcCtD
Vardenafil—Rash—Valproic Acid—migraine	0.000267	0.000754	CcSEcCtD
Vardenafil—Dermatitis—Valproic Acid—migraine	0.000267	0.000753	CcSEcCtD
Vardenafil—Pruritus—Timolol—migraine	0.000267	0.000753	CcSEcCtD
Vardenafil—Headache—Valproic Acid—migraine	0.000266	0.000749	CcSEcCtD
Vardenafil—Paraesthesia—Topiramate—migraine	0.000266	0.000749	CcSEcCtD
Vardenafil—PDE11A—Signaling by GPCR—CALCA—migraine	0.000265	0.00394	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HTR1D—migraine	0.000265	0.00393	CbGpPWpGaD
Vardenafil—Dyspnoea—Topiramate—migraine	0.000264	0.000743	CcSEcCtD
Vardenafil—Somnolence—Topiramate—migraine	0.000263	0.000741	CcSEcCtD
Vardenafil—PDE10A—Signaling by GPCR—HTR1A—migraine	0.000261	0.00388	CbGpPWpGaD
Vardenafil—Dyspepsia—Topiramate—migraine	0.00026	0.000734	CcSEcCtD
Vardenafil—PDE10A—GPCR downstream signaling—CALCA—migraine	0.00026	0.00386	CbGpPWpGaD
Vardenafil—Hypersensitivity—Gabapentin—migraine	0.000259	0.00073	CcSEcCtD
Vardenafil—Diarrhoea—Timolol—migraine	0.000258	0.000728	CcSEcCtD
Vardenafil—PDE10A—Signaling by GPCR—TAC1—migraine	0.000257	0.00382	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—NPS—migraine	0.000257	0.00382	CbGpPWpGaD
Vardenafil—Gastrointestinal disorder—Topiramate—migraine	0.000255	0.00072	CcSEcCtD
Vardenafil—Pain—Topiramate—migraine	0.000253	0.000713	CcSEcCtD
Vardenafil—PDE6G—Signaling Pathways—HTR2B—migraine	0.000252	0.00375	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—HTR2C—migraine	0.000252	0.00375	CbGpPWpGaD
Vardenafil—Asthenia—Gabapentin—migraine	0.000252	0.000711	CcSEcCtD
Vardenafil—Nausea—Valproic Acid—migraine	0.000252	0.00071	CcSEcCtD
Vardenafil—PDE1B—GPCR downstream signaling—HTR1D—migraine	0.00025	0.00371	CbGpPWpGaD
Vardenafil—Dizziness—Timolol—migraine	0.00025	0.000704	CcSEcCtD
Vardenafil—Pruritus—Gabapentin—migraine	0.000249	0.000701	CcSEcCtD
Vardenafil—PDE11A—Signaling by GPCR—HTR7—migraine	0.000248	0.00368	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HTR2B—migraine	0.000246	0.00365	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—EDNRA—migraine	0.000245	0.00364	CbGpPWpGaD
Vardenafil—Feeling abnormal—Topiramate—migraine	0.000244	0.000687	CcSEcCtD
Vardenafil—PDE10A—GPCR downstream signaling—HTR7—migraine	0.000243	0.00361	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—LRP1—migraine	0.000243	0.00361	CbGpPWpGaD
Vardenafil—Gastrointestinal pain—Topiramate—migraine	0.000242	0.000682	CcSEcCtD
Vardenafil—Diarrhoea—Gabapentin—migraine	0.00024	0.000678	CcSEcCtD
Vardenafil—Vomiting—Timolol—migraine	0.00024	0.000677	CcSEcCtD
Vardenafil—Rash—Timolol—migraine	0.000238	0.000671	CcSEcCtD
Vardenafil—Dermatitis—Timolol—migraine	0.000238	0.00067	CcSEcCtD
Vardenafil—Headache—Timolol—migraine	0.000236	0.000667	CcSEcCtD
Vardenafil—PDE10A—Signaling by GPCR—CALCA—migraine	0.000236	0.00351	CbGpPWpGaD
Vardenafil—Abdominal pain—Topiramate—migraine	0.000234	0.000659	CcSEcCtD
Vardenafil—Dizziness—Gabapentin—migraine	0.000232	0.000655	CcSEcCtD
Vardenafil—PDE1B—GPCR downstream signaling—HTR2B—migraine	0.000232	0.00345	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HTR1D—migraine	0.000227	0.00337	CbGpPWpGaD
Vardenafil—Nausea—Timolol—migraine	0.000224	0.000632	CcSEcCtD
Vardenafil—Vomiting—Gabapentin—migraine	0.000223	0.00063	CcSEcCtD
Vardenafil—PDE6G—Signaling Pathways—LRP1—migraine	0.000222	0.0033	CbGpPWpGaD
Vardenafil—Rash—Gabapentin—migraine	0.000222	0.000625	CcSEcCtD
Vardenafil—Dermatitis—Gabapentin—migraine	0.000221	0.000624	CcSEcCtD
Vardenafil—PDE10A—Signaling by GPCR—HTR7—migraine	0.000221	0.00328	CbGpPWpGaD
Vardenafil—Headache—Gabapentin—migraine	0.00022	0.000621	CcSEcCtD
Vardenafil—Hypersensitivity—Topiramate—migraine	0.000218	0.000614	CcSEcCtD
Vardenafil—PDE10A—Signaling Pathways—LRP1—migraine	0.000217	0.00322	CbGpPWpGaD
Vardenafil—Asthenia—Topiramate—migraine	0.000212	0.000598	CcSEcCtD
Vardenafil—PDE1B—Signaling by GPCR—HTR2B—migraine	0.000211	0.00313	CbGpPWpGaD
Vardenafil—Pruritus—Topiramate—migraine	0.000209	0.00059	CcSEcCtD
Vardenafil—Nausea—Gabapentin—migraine	0.000209	0.000589	CcSEcCtD
Vardenafil—PDE6G—Disease—CALCA—migraine	0.000204	0.00304	CbGpPWpGaD
Vardenafil—Diarrhoea—Topiramate—migraine	0.000202	0.000571	CcSEcCtD
Vardenafil—Dizziness—Topiramate—migraine	0.000196	0.000551	CcSEcCtD
Vardenafil—PDE11A—GPCR downstream signaling—HTR2A—migraine	0.000191	0.00284	CbGpPWpGaD
Vardenafil—Vomiting—Topiramate—migraine	0.000188	0.00053	CcSEcCtD
Vardenafil—Rash—Topiramate—migraine	0.000186	0.000526	CcSEcCtD
Vardenafil—PDE11A—Signaling Pathways—NOTCH4—migraine	0.000186	0.00277	CbGpPWpGaD
Vardenafil—Dermatitis—Topiramate—migraine	0.000186	0.000525	CcSEcCtD
Vardenafil—Headache—Topiramate—migraine	0.000185	0.000522	CcSEcCtD
Vardenafil—PDE1B—Signaling Pathways—CALCRL—migraine	0.000185	0.00274	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RAMP1—migraine	0.000185	0.00274	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HTR1B—migraine	0.00018	0.00267	CbGpPWpGaD
Vardenafil—Nausea—Topiramate—migraine	0.000176	0.000495	CcSEcCtD
Vardenafil—PDE11A—Signaling by GPCR—HTR2A—migraine	0.000174	0.00258	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HTR1A—migraine	0.000173	0.00257	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NPS—migraine	0.00017	0.00253	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PGR—migraine	0.00017	0.00253	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TAC1—migraine	0.00017	0.00253	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NOTCH4—migraine	0.00017	0.00253	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—HTR2A—migraine	0.00017	0.00253	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HTR2C—migraine	0.000167	0.00248	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NOTCH4—migraine	0.000166	0.00247	CbGpPWpGaD
Vardenafil—PDE6G—Disease—TGFBR2—migraine	0.000165	0.00245	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HTR1B—migraine	0.000164	0.00244	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—EDNRA—migraine	0.000163	0.00241	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HTR1B—migraine	0.00016	0.00238	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NOTCH3—migraine	0.000158	0.00235	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HTR1A—migraine	0.000158	0.00235	CbGpPWpGaD
Vardenafil—PDE1B—Disease—LRP1—migraine	0.000157	0.00233	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CALCA—migraine	0.000157	0.00232	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TAC1—migraine	0.000156	0.00232	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PGR—migraine	0.000156	0.00232	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NPS—migraine	0.000156	0.00232	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—HTR2A—migraine	0.000155	0.0023	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HTR1A—migraine	0.000154	0.00229	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HTR2C—migraine	0.000153	0.00227	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NPS—migraine	0.000152	0.00226	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PGR—migraine	0.000152	0.00226	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TAC1—migraine	0.000152	0.00226	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—HTR1B—migraine	0.000151	0.00225	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HTR2C—migraine	0.000149	0.00221	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EDNRA—migraine	0.000149	0.00221	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HTR7—migraine	0.000146	0.00217	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—HTR1A—migraine	0.000146	0.00216	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NOTCH3—migraine	0.000145	0.00215	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EDNRA—migraine	0.000145	0.00215	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—TAC1—migraine	0.000144	0.00213	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—NPS—migraine	0.000144	0.00213	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CALCA—migraine	0.000143	0.00213	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NOTCH3—migraine	0.000141	0.0021	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—HTR2C—migraine	0.000141	0.00209	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CALCA—migraine	0.00014	0.00207	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HTR1B—migraine	0.000138	0.00204	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—EDNRA—migraine	0.000137	0.00203	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR1D—migraine	0.000134	0.00199	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HTR7—migraine	0.000134	0.00199	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MTHFR—migraine	0.000134	0.00199	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HTR1A—migraine	0.000132	0.00197	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—CALCA—migraine	0.000132	0.00196	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HTR7—migraine	0.000131	0.00194	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—TAC1—migraine	0.00013	0.00194	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—NPS—migraine	0.00013	0.00194	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HTR2C—migraine	0.000128	0.0019	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TGFBR2—migraine	0.000126	0.00187	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR2B—migraine	0.000125	0.00185	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—EDNRA—migraine	0.000124	0.00185	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—HTR7—migraine	0.000123	0.00183	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—CALCA—migraine	0.00012	0.00178	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TGFBR2—migraine	0.000115	0.00171	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TGFBR2—migraine	0.000112	0.00167	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HTR7—migraine	0.000112	0.00166	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—LRP1—migraine	0.00011	0.00163	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HTR2A—migraine	0.000103	0.00152	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CALCA—migraine	0.000101	0.0015	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—FOS—migraine	9.84e-05	0.00146	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HTR2A—migraine	9.38e-05	0.00139	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HTR2A—migraine	9.14e-05	0.00136	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—ESR1—migraine	9.1e-05	0.00135	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—HTR2A—migraine	8.64e-05	0.00128	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOTCH4—migraine	8.42e-05	0.00125	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—ESR1—migraine	8.33e-05	0.00124	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TGFBR2—migraine	8.13e-05	0.00121	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR1B—migraine	8.12e-05	0.00121	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—ESR1—migraine	8.11e-05	0.0012	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HTR2A—migraine	7.84e-05	0.00116	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR1A—migraine	7.82e-05	0.00116	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TAC1—migraine	7.7e-05	0.00114	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NPS—migraine	7.7e-05	0.00114	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PGR—migraine	7.7e-05	0.00114	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR2C—migraine	7.55e-05	0.00112	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EDNRA—migraine	7.35e-05	0.00109	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOTCH3—migraine	7.16e-05	0.00106	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CALCA—migraine	7.07e-05	0.00105	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CACNA1A—migraine	6.66e-05	0.000989	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR7—migraine	6.61e-05	0.000982	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MTHFR—migraine	6.61e-05	0.000981	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—FOS—migraine	5.73e-05	0.000851	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFBR2—migraine	5.7e-05	0.000846	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HTR2A—migraine	4.63e-05	0.000688	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ESR1—migraine	4.11e-05	0.000611	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CACNA1A—migraine	3.1e-05	0.00046	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTHFR—migraine	2.2e-05	0.000327	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTHFR—migraine	1.02e-05	0.000152	CbGpPWpGaD
